Skip to main content
Publications
Turino C, Bertran S Characterization of the CPAP-treated patient population in Catalonia 10.1371/journal.pone.0185191
Panella P, Casas M, Donaire‐Gonzalez D, Garcia‐Esteban R Ultrafine particles and black carbon personal exposures in asthmatic and non-asthmatic children at school age 10.1111/ina.12382
Norback D, Zock JP, Plana E Building dampness and mould in European homes in relation to climate, building characteristics and socio-economic status: the European Community Respiratory Health Survey ECRHS II 10.1111/ina.12375
Bjornsdottir E, Janson C, Lindberg E, Arnardottir ES, Benediktsdottir B, Garcia-Aymerich J, Carsin AE Respiratory symptoms are more common among short sleepers independent of obesity 10.1136/bmjresp-2017-000206
Abdul-Jawad Altisent O, Puri R, Regueiro A, Chamandi C, Rodriguez-Gabella T, Del Trigo M, Campelo-Parada F, Couture T, Marsal JR Predictors and association with clinical outcomes of the changes in exercise capacity after transcatheter aortic valve replacement 10.1161/CIRCULATIONAHA.116.026349
Vert C, Sanchez-Benavides G, Martinez D Effect of long-term exposure to air pollution on anxiety and depression in adults: a cross-sectional study 10.1016/j.ijheh.2017.06.009
Vilanova MB, Falguera M, Marsal JR Prevalence, clinical features and risk assessment of pre-diabetes in Spain: the prospective Mollerussa cohort study 10.1136/bmjopen-2016-015158
Guerra S, Carsin AE Health-related quality of life and risk factors associated with spirometric restriction 10.1183/13993003.02096-2016
Bertelsen RJ, Rava M, Carsin AE Clinical markers of asthma and IgE assessed in parents before conception predict asthma and hayfever in the offspring 10.1111/cea.12906
Zijlema WL, Triguero-Mas M, Smith G, Cirach M, Martinez D The relationship between natural outdoor environments and cognitive functioning and its mediators 10.1016/j.envres.2017.02.017
Marzo-Ortega H, Halliday A, Jugl S, Mokashi S, Porter B, Talloczy Z, Sherif B Impact of alternative definitions of treatment response on long-term efficacy of secukinumab in tumour necrosis factor alpha-naïve patients with active ankylosing spondylitis
Temam S, Burte E, Adam M, Anto JM, Basagana X, Bousquet J, Carsin AE Socioeconomic position and outdoor nitrogen dioxide (NO2) exposure in Western Europe: a multi-city analysis 10.1016/j.envint.2016.12.026
Strober B, Gottlieb AB, Sherif B McLeod L Mordin M Gnanasakthy A Secukinumab sustains early patient-reported outcome benefits through 1 year: results from 2 phase III randomized placebo-controlled clinical trials comparing secukinumab with etanercept 10.1016/j.jaad.2016.11.043
Ensenyat A, Espigares-Tribo G, Machado L, Verdejo FJ, Rodriguez-Arregui R, Serrano J, Miret M, Galindo G, Blanco A, Marsal JR Metabolic risk management, physical exercise and lifestyle counselling in low-active adults: controlled randomized trial (BELLUGAT) 10.1186/s12889-017-4144-8
Triguero-Mas M, Gidlow CJ, Martinez D The effect of randomised exposure to different types of natural outdoor environments compared to exposure to an urban environment on people with indications of psychological distress in Catalonia
Boucher O, Julvez J, Guxens M, Arranz E, Ibarluzea J, Sanchez de Miguel M, Fernandez-Somoano A, Tardon A, Rebagliato M, Garcia-Esteban R Association between breastfeeding duration and cognitive development, autistic traits and ADHD symptoms: a multicenter study in Spain 10.1038/pr.2016.238
Tell-Marti G, Puig-Butille JA, Potrony M, Plana E A common variant in the MC1R gene (p.V92M) is associated with Alzheimer's disease risk 10.3233/JAD-161113
Fernandez-Barres S, Romaguera D, Valvi D, Martinez D Mediterranean dietary pattern in pregnant women and offspring risk of overweight and abdominal obesity in early childhood: the INMA birth cohort study 10.1111/ijpo.12092
Abdul-Jawad Altisent O, Durand E, Munoz-Garcia AJ, Nombela-Franco L, Cheema A, Kefer J, Gutierrez E, Benitez LM, Amat-Santos IJ, Serra V, Eltchaninoff H, Alnasser SM, Elizaga J, Dager A, Garcia Del Blanco B, Ortas-Nadal MDR, Marsal JR Reply: antithrombotic regimen in post-TAVR atrial fibrillation: not an easy decision 10.1016/j.jcin.2016.09.038
Strober B, Blauvelt A, Zhao Y, Milutinovic M, Mollon P, You R, Sherif B Secukinumab provides better relief from psoriasis-related pain, itching, and scaling than ustekinumab
Tyring S, Sofen H, Fretzin S, Rich P, Zhao Y, Herrera V, Sherif B Secukinumab provides better relief from quality-of-life impact than etanercept in moderate to severe psoriasis
Sofen H, Korman N, Rich P, Fretzin S, Zhao Y, Herrera V, Sherif B McLeod L Secukinumab provides better relief from quality-of-life impact than placebo in moderate to severe psoriasis
Blauvelt A, Korman N, Mollon P, Zhao Y, Milutinovic M, You R, Sherif B Secukinumab provides faster and better quality of life impact than ustekinumab in psoriasis
Tyring S, Sofen H, Fretzin S, Rich P, Zhao Y, Herrera V, Sherif B Secukinumab provides more effective relief from skin-related quality-of-life impact than etanercept in moderate to severe psoriasis
Sofen H, Korman N, Rich P, Fretzin S, Zhao Y, Herrera V, Sherif B McLeod L Secukinumab provides more effective relief from skin-related quality-of-life impact than placebo in moderate to severe psoriasis
Tyring S, Sofen H, Fretzin S, Rich P, Zhao Y, Herrera V, Sherif B Secukinumab provides more effective relief from skin-related quality-of-life impact than etanercept in moderate to severe psoriasis
Sofen H, Korman N, Rich P, Fretzin S, Zhao Y, Herrera V, Sherif B McLeod L Secukinumab provides more effective relief from skin-related quality-of-life impact than placebo in moderate to severe psoriasis
Strober B, Blauvelt A, Zhao Y, Milutinovic M, Mollon P, You R, Sherif B Secukinumab treatment provides more effective relief from patient-reported psoriasis-related pain, itching, and scaling than ustekinumab
